In vivo quantification of contrast agent concentration using the induced magnetic field for time-resolved arterial input function measurement with MRI

Medical Physics

Volumn 35, Issue 12, 2008, Pages 5328-5339

  De Rochefort, Ludovic ^a   Nguyen, Thanh ^a   Brown, Ryan ^a   Spincemaille, Pascal ^a   Choi, Grace ^a   Weinsaft, Jonathan ^a   Prince, Martin R ^a   Wang, Yi ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Arterial input function; Gadolinium; In vivo; Inversion; Magnetic field; MR contrast agent; Piece wise constant; Susceptibility quantification

Indexed keywords

ARCHES; BLOOD VESSELS; GADOLINIUM; IMAGE RECONSTRUCTION; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; PARAMAGNETISM;

ARTERIAL INPUT FUNCTION; IN-VIVO; INVERSION; MR CONTRAST AGENTS; PIECE-WISE CONSTANTS;

FLOW RATE;

GADOLINIUM;

ADULT; AGED; AORTA ARCH; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; FLOW RATE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MAGNETIC FIELD; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 56749184152     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3002309     Document Type: Article

References (55)

1. B. Meibohm and H. Derendorf, " Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.," Int. J. Clin. Pharmacol. Ther. 0946-1965 35 (10), 401-413 (1997); A. J. Atkinson, Jr. and R. L. Lalonde, '' Introduction of quantitative methods in pharmacology and clinical pharmacology: A historical overview.," Clin. Pharmacol. Ther. 82 (1), 3-6 (2007).
2. M. R. Prince, T. M. Grist, and J. F. Debatin, 3D Contrast MR Angiography (Springer, Berlin, 2003).
3. M. C. Schabel and D. L. Parker, " Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences.," Phys. Med. Biol. 53 (9), 2345-2373 (2008).
4. V. S. Lee, " Renal function measurements from MR renography and a simplified multicompartmental model.," Am. J. Physiol. Renal. Physiol. 292 (5), F1548-1559 (2007).
5. G. Duhamel, G. Schlaug, and D. C. Alsop, " Measurement of arterial input functions for dynamic susceptibility contrast magnetic resonance imaging using echoplanar images: Comparison of physical simulations with in vivo results.," Magn. Reson. Med. 55 (3), 514-523 (2006).
6. G. H. Jahng, " Sensitive and fast T1 mapping based on two inversion recovery images and a reference image.," Med. Phys. 32 (6), 1524-1528 (2005).
7. D. M. Higgins, " T1 measurement using a short acquisition period for quantitative cardiac applications.," Med. Phys. 0094-2405 10.1118/1.1921668 32 (6), 1738-1746 (2005); S. C. Deoni, B. K. Rutt, and T. M. Peters, " Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state.," Magn. Reson. Med. 49 (3), 515-526 (2003).
8. T. E. Conturo, " Arterial input functions for dynamic susceptibility contrast MRI: Requirements and signal options.," J. Magn. Reson Imaging 22 (6), 697-703 (2005).
9. M. K. Ivancevic, " Inflow effect correction in fast gradient-echo perfusion imaging.," Magn. Reson. Med. 50 (5), 885-891 (2003).
10. G. J. Stanisz and R. M. Henkelman, " Gd-DTPA relaxivity depends on macromolecular content.," Magn. Reson. Med. 44 (5), 665-667 (2000).
11. J. F. Schenck, " The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds.," Med. Phys. 0094-2405 10.1118/1.597854 23 (6), 815-850 (1996); D. Wang and Z. Yang, " A detailed study on the use of polynomial functions for modeling geometric distortion in magnetic resonance imaging.," Med. Phys. 0094-2405 10.1118/1.2839100 35 (3), 908-916 (2008); B. Muller-Bierl, " Compensation of magnetic field distortions from paramagnetic instruments by added diamagnetic material: Measurements and numerical simulations.," Med. Phys. 0094-2405 10.1118/1.1828674 32 (1), 76-84 (2005); B. Muller-Bierl, " Numerical modeling of needle tip artifacts in MR gradient echo imaging.," Med. Phys. 31 (3), 579-587 (2004).
12. E. Akbudak, R. E. Norberg, and T. E. Conturo, " Contrast-agent phase effects: An experimental system for analysis of susceptibility, concentration, and bolus input function kinetics.," Magn. Reson. Med. 0740-3194 38 (6), 990-1002 (1997); M. J. van Osch, " Measuring the arterial input function with gradient echo sequences.," Magn. Reson. Med. 0740-3194 49 (6), 1067-1076 (2003); R. W. Holt, " Mr Susceptometry-An external-phantom method for measuring bulk susceptibility from field-echo phase reconstruction maps.," J. Magn. Reson Imaging 4 (6), 809-818 (1994).
13. R. M. Weisskoff and S. Kiihne, " MRI susceptometry: Image-based measurement of absolute susceptibility of MR contrast agents and human blood.," Magn. Reson. Med. 24 (2), 375-383 (1992).
14. P. R. Moran, " A flow velocity zeugmatographic interlace for NMR imaging in humans.," Magn. Reson. Imaging 1, 197-203 (1983).
15. E. M. Haacke, Magnetic Resonance Imaging, Physical Principles and Sequence Design (Wiley, New York, 1999).
16. R. R. Edelman, " Gadolinium-enhanced off-resonance contrast angiography.," Magn. Reson. Med. 57 (3), 475-484 (2007).
17. E. J. Ribot, " Application of MRI phase-difference mapping to assessment of vascular concentrations of BMS agent in mice.," Contrast Media Mol Imaging 3 (2), 53-60 (2008).
18. Z. Chu, " MRI measurement of hepatic magnetic susceptibility-phantom validation and normal subject studies.," Magn. Reson. Med. 52 (6), 1318-1327 (2004).
19. M. A. Fernandez-Seara, " MR susceptometry for measuring global brain oxygen extraction.," Magn. Reson. Med. 55 (5), 967-973 (2006).
20. Y. Wang, " Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA.," J. Magn. Reson. Imaging 12 (5), 661-670 (2000).
21. G. O. Cron, " A comparison of T2*-weighted magnitude and phase imaging for measuring the arterial input function in the rat aorta following intravenous injection of gadolinium contrast agent.," Magn. Reson. Imaging 23 (5), 619-627 (2005).
22. M. S. Kotys, " Precision, signal-to-noise ratio, and dose optimization of magnitude and phase arterial input functions in dynamic susceptibility contrast MRI.," J. Magn. Reson. Imaging 25 (3), 598-611 (2007).
23. E. M. Haacke, " Imaging iron stores in the brain using magnetic resonance imaging.," Magn. Reson. Imaging 23 (1), 1-25 (2005).
24. M. S. Albert, " Susceptibility changes following bolus injections.," Magn. Reson. Med. 29 (5), 700-708 (1993).
25. R. Salomir, B. D. De Senneville, and C. T. W. Moonen, " A fast calculation method for magnetic field inhomogeneity due to an arbitrary distribution of bulk susceptibility.," Concepts in Magnetic Resonance Part B-Magnetic Resonance Engineering 19B (1), 26-34 (2003).
26. J. C. de Munck, " The computation of MR image distortions caused by tissue susceptibility using the boundary element method.," IEEE Trans. Med. Imaging 15 (5), 620-627 (1996).
27. J. D. Jackson, Classical Electrodynamics, 3rd ed. (Wiley, New York, 1999).
28. A. Bjork, in Numerical Methods for Least Squares Problems (SIAM, Society for Industrial and Applied Mathematics, Philadelphia, 1996), pp. 165-186.
29. J. H. Zar, Biostatistical Analysis, 3rd ed. (Prentice-Hall, Englewood Cliffs, NJ, 1996).
30. K. P. Pruessmann, " SENSE: Sensitivity encoding for fast MRI.," Magn. Reson. Med. 42 (5), 952-962 (1999).
31. T. E. Conturo and G. D. Smith, " Signal-to-noise in phase angle reconstruction: Dynamic range extension using phase reference offsets.," Magn. Reson. Med. 15 (3), 420-437 (1990).
32. O. Kahn, Molecular Magnetism (Wiley-VCH, Weinheim, 1993).
33. P. Meier and K. L. Zierler, " On the theory of the indicator-dilution method for measurement of blood flow and volume.," J. Appl. Physiol. 6 (12), 731-744 (1954).
34. C. W. Sheppard and M. B. Uffer, " Stochastic models for tracer experiments in the circulation. II. Serial random walks.," J. Theor. Biol. 22 (1), 188-207 (1969).
35. R. K. Millard, " Indicator-dilution dispersion models and cardiac output computing methods.," Am. J. Physiol. 272 (4 Pt 2), H2004-2012 (1997).
36. J. Lotz, " Cardiovascular flow measurement with phase-contrast MR imaging: Basic facts and implementation.," Radiographics 22 (3), 651-671 (2002); P. Chai and R. Mohiaddin, " How we perform cardiovascular magnetic resonance flow assessment using phase-contrast velocity mapping.," J. Cardiovasc. Magn. Reson. 7 (4), 705-716 (2005).
37. W. G. Hundley, " Quantitation of cardiac output with velocity-encoded, phase-difference magnetic resonance imaging.," Am. J. Cardiol. 75 (17), 1250-1255 (1995).
38. J. M. Bland and D. G. Altman, " Statistical methods for assessing agreement between two methods of clinical measurement.," Lancet 1 (8476), 307-310 (1986).
39. L. Li and J. S. Leigh, " Quantifying arbitrary magnetic susceptibility distributions with MR.," Magn. Reson. Med. 51 (5), 1077-1082 (2004).
40. J. Wang, " Factors influencing flip angle mapping in MRI: RF pulse shape, slice-select gradients, off-resonance excitation, and B0 inhomogeneities.," Magn. Reson. Med. 56 (2), 463-468 (2006).
41. R. M. Setser, " Cine delayed-enhancement MR imaging of the heart: Initial experience.," Radiology 239 (3), 856-862 (2006).
42. C. E. Barbier, " The exactness of left ventricular segmentation in cine magnetic resonance imaging and its impact on systolic function values.," Acta Radiol. 48 (3), 285-291 (2007).
43. N. Hackstein, J. Heckrodt, and W. S. Rau, " Measurement of single-kidney glomerular filtration rate using a constrast-enhanced dynamic gradient-echo sequence and the Rutland-Patlak plot technique.," J. Magn. Reson Imaging 18 (6), 714-725 (2003).
44. J. L. Dimicoli, " On the use of R1 and R2* for measurement of contrast agent concentration in isolated perfused rat liver.," NMR Biomed. 16 (5), 276-285 (2003).
45. F. Risse, " Dual-bolus approach to quantitative measurement of pulmonary perfusion by contrast-enhanced MRI.," J. Magn. Reson Imaging 24 (6), 1284-1290 (2006).
46. V. G. Kiselev, " Transverse relaxation effect of MRI contrast agents: A crucial issue for quantitative measurements of cerebral perfusion.," J. Magn. Reson Imaging 22 (6), 693-696 (2005).
47. D. Kim, " Influence of the k-space trajectory on the dynamic T(1)-weighted signal in quantitative first-pass cardiac perfusion MRI at 3T.," Magn. Reson. Med. 59 (1), 202-208 (2008).
48. F. Calamante, E. J. Vonken, and M. J. van Osch, " Contrast agent concentration measurements affecting quantification of bolus-tracking perfusion MRI.," Magn. Reson. Med. 58 (3), 544-553 (2007).
49. M. J. van Osch, J. van der Grond, and C. J. Bakker, " Partial volume effects on arterial input functions: Shape and amplitude distortions and their correction.," J. Magn. Reson Imaging 22 (6), 704-709 (2005).
50. J. Bremerich, D. Bilecen, and P. Reimer, " MR angiography with blood pool contrast agents.," Eur. Radiol. 17 (12), 3017-3024 (2007).
51. C. W. Jung and P. Jacobs, " Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsil.," Magn. Reson. Imaging 13 (5), 661-674 (1995).
52. C. J. Durrant, M. P. Hertzberg, and P. W. Kuchel, " Magnetic susceptibility: Further insights into macroscopic and microscopic fields and the sphere of Lorentz.," Concepts Magn. Reson. 18A (1), 72-95 (2003).
53. V. B. Berestetskii, E. M. Lifshitz, and L. P. Pitaevskii, in Course of Theoretical Physics, edited by, L. Landau, (Elsevier, New York, 1982), Vol. 4, p. 340.
54. R. E. Hoffman, " Measurement of magnetic susceptibility and calculation of shape factor of NMR samples.," J. Magn. Reson. 178 (2), 237-247 (2006).
55. J. C. de Munck, " A linear discretization of the volume conductor boundary integral-equation using analytically integrated elements.," IEEE Trans. Biomed. Eng. 39 (9), 986-990 (1992).